PortalPublikationenCirculating epithelial cells in patients with benign colon d...

Circulating epithelial cells in patients with benign colon diseases.

Standard

Circulating epithelial cells in patients with benign colon diseases. / Pantel, Klaus; Denève, Eric; Nocca, David; Coffy, Amandine; Vendrell, Jean-Pierre; Maudelonde, Thierry; Riethdorf, Sabine; Alix-Panabières, Catherine.

in: CLIN CHEM, Jahrgang 58, Nr. 5, 5, 2012, S. 936-940.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Pantel, K, Denève, E, Nocca, D, Coffy, A, Vendrell, J-P, Maudelonde, T, Riethdorf, S & Alix-Panabières, C 2012, 'Circulating epithelial cells in patients with benign colon diseases.', CLIN CHEM, Jg. 58, Nr. 5, 5, S. 936-940. <http://www.ncbi.nlm.nih.gov/pubmed/22205690?dopt=Citation>

APA

Pantel, K., Denève, E., Nocca, D., Coffy, A., Vendrell, J-P., Maudelonde, T., Riethdorf, S., & Alix-Panabières, C. (2012). Circulating epithelial cells in patients with benign colon diseases. CLIN CHEM, 58(5), 936-940. [5]. http://www.ncbi.nlm.nih.gov/pubmed/22205690?dopt=Citation

Vancouver

Pantel K, Denève E, Nocca D, Coffy A, Vendrell J-P, Maudelonde T et al. Circulating epithelial cells in patients with benign colon diseases. CLIN CHEM. 2012;58(5):936-940. 5.

Bibtex

@article{aea205ab44b345d9a9cbd6c26f9d9bc4,
title = "Circulating epithelial cells in patients with benign colon diseases.",
abstract = "Detection of circulating tumor cells (CTCs) in the peripheral blood is a rapidly developing research field with clear clinical implications for the staging and monitoring of cancer patients. Current CTC assays, including the US Food and Drug Administration-cleared CellSearch{\textregistered} system, typically use markers [e.g., cytokeratins (CKs), the transmembrane protein EpCAM (epithelial cell adhesion molecule)] that are expressed on normal and malignant epithelial cells but not on the surrounding normal leukocytes.",
author = "Klaus Pantel and Eric Den{\`e}ve and David Nocca and Amandine Coffy and Jean-Pierre Vendrell and Thierry Maudelonde and Sabine Riethdorf and Catherine Alix-Panabi{\`e}res",
year = "2012",
language = "English",
volume = "58",
pages = "936--940",
journal = "CLIN CHEM",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Circulating epithelial cells in patients with benign colon diseases.

AU - Pantel, Klaus

AU - Denève, Eric

AU - Nocca, David

AU - Coffy, Amandine

AU - Vendrell, Jean-Pierre

AU - Maudelonde, Thierry

AU - Riethdorf, Sabine

AU - Alix-Panabières, Catherine

PY - 2012

Y1 - 2012

N2 - Detection of circulating tumor cells (CTCs) in the peripheral blood is a rapidly developing research field with clear clinical implications for the staging and monitoring of cancer patients. Current CTC assays, including the US Food and Drug Administration-cleared CellSearch® system, typically use markers [e.g., cytokeratins (CKs), the transmembrane protein EpCAM (epithelial cell adhesion molecule)] that are expressed on normal and malignant epithelial cells but not on the surrounding normal leukocytes.

AB - Detection of circulating tumor cells (CTCs) in the peripheral blood is a rapidly developing research field with clear clinical implications for the staging and monitoring of cancer patients. Current CTC assays, including the US Food and Drug Administration-cleared CellSearch® system, typically use markers [e.g., cytokeratins (CKs), the transmembrane protein EpCAM (epithelial cell adhesion molecule)] that are expressed on normal and malignant epithelial cells but not on the surrounding normal leukocytes.

M3 - SCORING: Journal article

VL - 58

SP - 936

EP - 940

JO - CLIN CHEM

JF - CLIN CHEM

SN - 0009-9147

IS - 5

M1 - 5

ER -